Isolation and neuroprotective prospective of novel bioactive compound "3-(3,4-dimethoxyphenyl)-1-(4-methoxyphenyl) prop-2-en-1-one" against ketamine-induced cognitive deficits in schizophrenia: an experimental study.

In conclusion, this is the first study of new flavonoid compound of CP and its protective efficacy against schizophrenia. PMID: 33415998 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33415998?dopt=Abstract

Source: Natural Product Research - January 8, 2021 Category: Biochemistry Authors: Chintha V, Wudayagiri R Tags: Nat Prod Res Source Type: research